Status:
RECRUITING
Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Gastric Cancer
Immunonutrition
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Glutamine has the potentials of immunomodulation and adjustment of protein metabolism. The primary objective of this study is to evaluate the efficacy of glutamine on sarcopenia in gastric adenocarcin...
Detailed Description
This will be a double-blind, randomized, and placebo-controlled study. At least 80 evaluable patients who are scheduled for gastrectomy for gastric adenocarcinoma cancer will be randomly assigned to t...
Eligibility Criteria
Inclusion
- adult gastric cancer receiving gastrectomy
Exclusion
- Hepatic insufficiency
- Renal insufficiency
- can not tolerate oral or enteral feeding 7 days after gastrectomy
- can not receive computed tomograph
- can not waer the wearable devices
Key Trial Info
Start Date :
February 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06027242
Start Date
February 21 2023
End Date
August 30 2026
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100